Download PDF
Semin Liver Dis 2000; Volume 20(Number 01): 0069-0084
DOI: 10.1055/s-2000-9504
Copyright © 2000 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4663

Biochemical and Immunologic Properties of the Nonstructural Proteins of the Hepatitis C Virus: Implications for Development of Antiviral Agents and Vaccines

Raffaele De Francesco, Petra Neddermann, Licia Tomei, Christian Steinkühler, Paola Gallinari, Antonella Folgori
  • Istituto di Ricerche di Biologia Molecolare, ``P. Angeletti,'' Pomezia, Rome, Italy
Further Information

Publication History

Publication Date:
31 December 2000 (online)

    Permissions and Reprints

ABSTRACT

Infection with the hepatitis C virus (HCV) is the major cause of non-A, non-B hepatitis worldwide. The viral genome, a positive-sense, single-stranded, 9.6-kb long RNA molecule, is translated into a single polyprotein of about 3,000 amino acids. The viral polyprotein is proteoytically processed to yield all the mature viral gene products. The genomic order of HCV has been determined to be C → E1 → E2 → p7 → NS2 → NS3 → NS4A → NS4B → NS5A → NS5B. C, E1, and E2 are the virion structural proteins. Whereas the function of p7 is currently unknown, NS2 to NS5B are thought to be the nonstructural proteins. Generation of the mature nonstructural proteins relies on the activity of viral proteinases. Cleavage at the NS2-NS3 junction is accomplished by a metal-dependent autocatalytic proteinase encoded within NS2 and the N-terminus of NS3. The remaining downstream cleavages are effected by a serine proteinase contained also within the N-terminal region of NS3. NS3, in addition, contains an RNA helicase domain at its C-terminus. NS3 forms a heterodimeric complex with NS4A. The latter is a membrane protein that acts as a cofactor of the proteinase. Although no function has yet been attributed to NS4B, NS5A has been recently suggested to be involved in mediating the resistance of the HCV to the action of interferon. Finally, the NS5B protein has been shown to be the viral RNA-dependent RNA polymerase. This article reviews the current understanding of the structure and the function of the various HCV nonstructural proteins with particular emphasis on their potential as targets for the development of novel antiviral agents and vaccines.

KEYWORD

virus - replication

REFERENCES

  • 1 Lohmann V, Koch J O, Bartenschlager R. Processing pathways of the hepatitis C virus proteins.  J Hepatol . 1996;  24 11-19
    PubMedGoogle Scholar
  • 2 Grakoui A, Wychowski C, Lin C. Expression and identification of hepatitis C virus polyprotein cleavage products.  J Virol . 1993;  67 1385-1395
    PubMedGoogle Scholar
  • 3 Tomei L, Failla C, Santolini E. NS3 is a serine proteinase required for processing of hepatitis C virus polyprotein.  J Virol . 1993;  67 4017-4026
    PubMedGoogle Scholar
  • 4 Bartenschlager R, Ahlborn-Laake L, Mous J. Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions.  J Virol . 1993;  67 3835-3844
    PubMedGoogle Scholar
  • 5 Manabe S, Fuke I, Tanishita O. Production of nonstructural proteins of hepatitis C virus requires a putative viral proteinase encoded by NS3.  Virology . 1994;  198 636-644
    CrossrefPubMedGoogle Scholar
  • 6 D'Souza E DA, O'Sullivan E, Amphlett E M. Analysis of NS3-mediated processing of the hepatitis C virus non-structural region in vitro.  J Gen Virol . 1994;  75 3469-3476
    PubMedGoogle Scholar
  • 7 Failla C, Tomei L, De Francesco R. Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins.  J Virol . 1994;  68 3753-3760
    PubMedGoogle Scholar
  • 8 Kolykhalov A, Mihalik K, Feinstone S M. Four enzymaticactivities and the 3′conserved sequence are essential for HCV replication. 6th International Symposium on Hepatitis C & Related Viruses, Bethesda, MD, 1999
    Google Scholar
  • 9 Grakoui A, McCourt D W, Wychowski C. A second hepatitis C virus-encoded proteinase.  Proc Natl Acad Sci USA . 1993;  90 10583-10587
    PubMedGoogle Scholar
  • 10 Hijikata M, Mizushima H, Akagi T. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus.  J Virol . 1993;  67 4665-4675
    PubMedGoogle Scholar
  • 11 Reed K E, Grakoui A, Rice C M. Hepatitis C virus-encoded NS2-3 proteinase: cleavage-site mutagenesis and requirements for bimolecular cleavage.  J Virol . 1995;  69 4127-4136
    PubMedGoogle Scholar
  • 12 Santolini E, Pacini L, Fipaldini C. The NS2 protein of hepatitis C virus is a transmembrane polypeptide.  J Virol . 1995;  69 7461-7471
    PubMedGoogle Scholar
  • 13 Pieroni L, Santolini E, Fipaldini C. In vitro study of the NS2-3 protease of hepatitis C virus.  J Virol . 1997;  71 6373-6380
    PubMedGoogle Scholar
  • 14 De Francesco R, Urbani A, Nardi M C. A zinc binding site in viral serine proteinases.  Biochemistry. 1996;  35 13282-13287
    CrossrefPubMedGoogle Scholar
  • 15 Kim J L, Morgenstern K A, Lin C. Crystal structure of the hepatitis virus NS3 proteinase domain complexed with a synthetic NS4A cofactor peptide.  Cell . 1996;  87 343-355
    CrossrefPubMedGoogle Scholar
  • 16 Love R A, Parge H E, Wickersham J A. The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site.  Cell . 1996;  87 331-342
    CrossrefPubMedGoogle Scholar
  • 17 Yan Y, Li Y, Munshi S. Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: A 2.2 Å resolution structure in a hexagonal crystal form.  Protein Sci . 1998;  7 837-847
    PubMedGoogle Scholar
  • 18 Wu Z, Yao N, Le H V. Mechanism of autoproteolysis at the NS2-NS3 junction of the hepatitis C virus polyprotein.  Trends Biochem Sci . 1998;  23 92-94
    CrossrefPubMedGoogle Scholar
  • 19 Gorbalenya A E, Snijder E J. Viral cysteine proteinases.  Perspect Drug Discovery Design . 1996;  6 64-86
    PubMedGoogle Scholar
  • 20 Urbani A, Bazzo R, Nardi M C. The metal binding site of the hepatitis C virus NS3 protease A spectroscopic study.  J Biol Chem . 1998;  273 18760-18769
    CrossrefPubMedGoogle Scholar
  • 21 Failla C, Tomei L, De Francesco R. An amino-terminal domain of the hepatitis C virus NS3 proteinase is essential for interaction with NS4A.  J Virol . 1995;  69 1769-1777
    PubMedGoogle Scholar
  • 22 Bartenschlager R, Ahlborn Laake L, Mous J. Kinetic and structural analyses of hepatitis C virus polyprotein processing.  J Virol . 1994;  68 5045-5055
    PubMedGoogle Scholar
  • 23 Tanji Y, Hijikata M, Hirowatari Y. Hepatitis C virus polyprotein processing: Kinetics and mutagenic analysis of serine proteinase-dependent cleavage.  J Virol . 1994;  68 8418-8422
    PubMedGoogle Scholar
  • 24 Han D S, Hahm B, Rho H M. Identification of the serine protease domain in NS3 of the hepatitis C virus.  J Gen Virol . 1995;  76 985-993
    PubMedGoogle Scholar
  • 25 Kolykhalov A A, Agapov E V, Rice C M. Specificity of the hepatitis C virus NS3 serine proteinase: Effects of substitutions at the 3/4A, 4A/4B, 4B/5A, and 5A/5B cleavage sites on polyprotein processing.  J Virol . 1994;  68 7525-7533
    PubMedGoogle Scholar
  • 26 Gallinari P, Paolini C, Brennan D. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A.  Biochemistry . 1999;  38 5620-5632
    CrossrefPubMedGoogle Scholar
  • 27 Satoh S, Tanji Y, Hijikata M. The N-terminal region of hepatitis C virus nonstructural protein 3 (NS3) is essential for stable complex formation with NS4A.  J Virol . 1995;  69 4255-4260
    PubMedGoogle Scholar
  • 28 Koch J O, Lohmann V, Herian U. In vitro studies on the activation of the hepatitis C virus NS3 proteinase by the NS4A cofactor.  Virology . 1996;  221 54-66
    CrossrefPubMedGoogle Scholar
  • 29 Tanji Y, Hijikata M, Satoh S. Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing.  J Virol . 1995;  69 1575-1581
    PubMedGoogle Scholar
  • 30 Lin C, Rice C M. The hepatitis C virus NS3 proteinase and NS4A co-factor: Establishment of a cell-free trans-processing assay.  Proc Natl Acad Sci USA . 1995;  92 7622-7626
    PubMedGoogle Scholar
  • 31 Shimizu Y, Yamaji K, Masuho Y. Identification of the sequence of NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 proteinase.  J Virol . 1996;  70 127-132
    PubMedGoogle Scholar
  • 32 Tomei L, Failla C, Vitale M R. A central hydrophobic domain of the hepatitis C virus NS4A protein is necessary and sufficient for the activation of the NS3 protease.  J Gen Virol . 1995;  77 1065-1070
    PubMedGoogle Scholar
  • 33 Barbato G, Cicero D O, Nardi M C. The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanism.  J Mol Biol . 1999;  289 371-384
    CrossrefPubMedGoogle Scholar
  • 34 Stempniak M, Hostomska Z, Nodes B R. The NS3 proteinase domain of hepatitis C virus is a zinc-containing enzyme.  J Virol . 1997;  71 2881-2886
    PubMedGoogle Scholar
  • 35 Petersen J FW, Cherney M M, Liebig H-D. The structure of the 2A proteinase from a common cold virus: A proteinase responsible for the shut-off of host-cell protein synthesis.  EMBO J . 1999;  18 5463-5475
    CrossrefPubMedGoogle Scholar
  • 36 Schechter I, Berger A. On the size of the active site in proteinases I Papain.  Biochem Biophys Res Commun . 1967;  27 157-162
    CrossrefPubMedGoogle Scholar
  • 37 Pizzi E, Tramontano A, Tomei L. Molecular model of the specificity pocket of the hepatitis C virus proteinase: Implications for substrate recognition.  Proc Natl Acad Sci USA . 1994;  91 888-892
    PubMedGoogle Scholar
  • 38 Urbani A, Bianchi E, Narjes F. Substrate specificity of the hepatitis C virus serine protease NS3.  J Biol Chem . 1997;  272 9204-9209
    CrossrefPubMedGoogle Scholar
  • 39 Zhang R, Durkin J, Windsor W T. Probing the substrate specificity of hepatitis C virus NS3 serine protease by using synthetic peptides.  J Virol . 1997;  71 6208-6213
    PubMedGoogle Scholar
  • 40 Steinkühler C, Urbani A, Tomei L. Activity of purified hepatitis C virus proteinase NS3 on peptide substrates.  J Virol . 1996;  70 6694-6700
    PubMedGoogle Scholar
  • 41 Steinkühler C, Biasiol G, Brunetti M. Product inhibition of the hepatitis C virus NS3 protease.  Biochemistry . 1998;  37 8899-8905
    CrossrefPubMedGoogle Scholar
  • 42 Llinas-Brunet M, Bailey M, Fazal G. Peptide-based inhibitors of the hepatitis C virus serine protease.  Bioorg Med Chem Lett . 1998;  8 1713-1718
    CrossrefPubMedGoogle Scholar
  • 43 Llinas-Brunet M, Bailey M, Deziel R. Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine protease.  Bioorg Med Chem Lett . 1998;  8 2719-2724
    CrossrefPubMedGoogle Scholar
  • 44 LaPlante S R, Cameron D R, Aubry N. Solution structure of substrate-based ligands when bound to hepatitis C virus NS3 protease domain.  J Biol Chem . 1999;  274 18618-18624
    CrossrefPubMedGoogle Scholar
  • 45 Cicero D O, Barbato G, Koch U. Structural characterization of the interactions of optimized product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modelling studies.  J Mol Biol . 1999;  289 385-396
    CrossrefPubMedGoogle Scholar
  • 46 Yao N, Reichert P, Taremi S S. Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase.  Structure . 1999;  7 1353-1363
    CrossrefPubMedGoogle Scholar
  • 47 Ingallinella P, Altamura S, Bianchi E. Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products.  Biochemistry . 1998;  37 8906-8914
    CrossrefPubMedGoogle Scholar
  • 48 Gorbalenya A E, Koonin E V. Helicases: Amino acid sequence comparison and structure-function relationship.  Curr Opin Struct Biol . 1993;  3 419-429
    CrossrefPubMedGoogle Scholar
  • 49 Suzich J A, Tamura J K, Palmer Hill F. Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes.  J Virol . 1993;  67 6152-6158
    PubMedGoogle Scholar
  • 50 Gwack Y, Wook D, Han J H. NTPase activity of hepatitis C virus NS3 protein expressed in insect cells.  Mol Cells . 1995;  5 171-175
    PubMedGoogle Scholar
  • 51 Preugschat F, Averett D R, Clarke B E. A steady-state and pre-steady state kinetic analysis of the NTPase activity associated with the hepatitis C virus NS3 helicase domain.  J Biol Chem . 1996;  271 24449-24457
    CrossrefPubMedGoogle Scholar
  • 52 Porter D JT. A kinetic analysis of the oligonucleotide-modulated ATPase activity of the helicase Domain of the NS3 protein from hepatitis C virus.  J Biol Chem . 1998;  273 14247-14253
    CrossrefPubMedGoogle Scholar
  • 53 Kim D W, Gwack Y, Han J H. C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity.  Biochem Biophys Res Commun . 1995;  215 160-166
    CrossrefPubMedGoogle Scholar
  • 54 Jin L, Peterson D L. Expression, isolation, and characterization of the hepatitis C virus ATPase/RNA helicase.  Arch Biochem Biophys . 1995;  323 47-53
    CrossrefPubMedGoogle Scholar
  • 55 Tai C L, Chi W K, Chen D S. The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3).  J Virol . 1996;  70 8477-8484
    PubMedGoogle Scholar
  • 56 Gwack Y, Kim D W, Han J H. Characterization of RNA binding activity and RNA helicase activity of the hepatitis C virus NS3 protein.  Biochem Biophys Res Commun . 1996;  225 654-659
    CrossrefPubMedGoogle Scholar
  • 57 Porter D JT, Short S A, Hanlon M H. Product release is the major contributor to kcat for the hepatitis C virus helicase-catalyzed strand separation of short duplex DNA.  J Biol Chem . 1998;  273 18906-18914
    CrossrefPubMedGoogle Scholar
  • 58 Kanai A, Tanabe K, Kohara M. Poly(U) binding activity of hepatitis C virus NS3 protein, a putative RNA helicase.  FEBS Lett . 1995;  376 221-224
    CrossrefPubMedGoogle Scholar
  • 59 Gallinari P, Brennan D, Nardi C. Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus.  J Virol . 1998;  72 6758-6769
    PubMedGoogle Scholar
  • 60 Gorbalenya A E, Koonin E V, Donchenko A P. Two related superfamilies of putative helicases involved in replication, recombination, repair and expression of DNA and RNA genomes.  Nucleic Acids Res . 1989;  17 4713-4730
    PubMedGoogle Scholar
  • 61 Gorbalenya A E, Koonin E V, Wolf Y I. A new family of putative NTP-binding domains encoded by genomes of small DNA and RNA viruses.  FEBS Lett . 1990;  262 145-148
    CrossrefPubMedGoogle Scholar
  • 62 Heilek G M, Peterson M G. A point mutation abolishes the helicase but not the nucleoside triphosphatase activity of hepatitis C virus NS3 protein.  J Virol . 1997;  71 6264-6266
    PubMedGoogle Scholar
  • 63 Kim D W, Kim J, Gwack Y. Mutational analysis of the hepatitis C virus RNA helicase.  J Virol . 1997;  71 9400-9409
    PubMedGoogle Scholar
  • 64 Wardell A D, Errington W, Ciaramella G. Characterization and mutational analysis of the helicase and NTPase activities of hepatitis C virus full-length NS3 protein.  J Gen Virol . 1999;  80 701-709
    PubMedGoogle Scholar
  • 65 Yao N, Hesson T, Cable M. Structure of the hepatitis C virus RNA helicase domain.  Nature Struct Biol . 1997;  4 463-467
    CrossrefPubMedGoogle Scholar
  • 66 Kim J R, Morgernstern K A, Griffith J P. Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: The crystal structure provides insights into the mode of unwinding.  Structure . 1998;  6 89-100
    CrossrefPubMedGoogle Scholar
  • 67 Cho H S, Ha N C, Kang L W. Crystal structure of RNA helicase from genotype 1b hepatitis C virus.  J Biol Chem . 1998;  273 15045-15052
    CrossrefPubMedGoogle Scholar
  • 68 Subramanya H S, Bird L E, Brannigan J A. Crystal structure of a DExx box helicase.  Nature . 1996;  384 379-383
    CrossrefPubMedGoogle Scholar
  • 69 Korolev S, Yao N, Lohman T M. Comparisons between the structures of HCV and Rep helicases reveal structural similarities between SF1 and SF2 super-families of helicases.  Protein Sci . 1998;  7 605-610
    PubMedGoogle Scholar
  • 70 Velankar S S, Soultanas P, Dillingham M S. Crystal structures of complexes of PcrA DNA helicase with a DNA substrate indicate an inchworm mechanism.  Cell . 1999;  97 75-84
    CrossrefPubMedGoogle Scholar
  • 71 Bird L E, Subramanya H S, Wingley D B. Helicases: A unifying structural theme?.  Curr Opin Struct Biol . 1998;  8 14-18
    CrossrefPubMedGoogle Scholar
  • 72 Korolev S, Hsieh J, Gauss G H. Major domain swiveling revealed by the crystal structures of complexes of E coli Rep helicase bound to single-stranded DNA and ADP.  Cell . 1997;  90 635-647
    CrossrefPubMedGoogle Scholar
  • 73 Lin C, Kim J L. Structure-based mutagenesis study of hepatitis C virus NS3 helicase.  J Virol . 1999;  73 8798-8807
    PubMedGoogle Scholar
  • 74 Kaneko T, Tanji Y, Satoh S. Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome.  Biochem Biophys Res Commun . 1994;  205 320-326
    CrossrefPubMedGoogle Scholar
  • 75 Tanji Y, Kaneko T, Satoh S. Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A.  J Virol . 1995;  69 3980-3986
    PubMedGoogle Scholar
  • 76 Reed K E, Rice C M. Identification of the major phosphorylation site of the hepatitis C virus H strain NS5A proteins as serine 2321.  J Biol Chem . 1999;  274 28011-28018
    CrossrefPubMedGoogle Scholar
  • 77 Hirota M, Satoh S, Asabe S I. Phosphorylation of nonstructural 5A protein of hepatitis C virus: HCV group-specific hyperphosphorylation.  Virology . 1999;  257 130-137
    CrossrefPubMedGoogle Scholar
  • 78 Liu Q, Bhat R A, Prince A M. The hepatitis C virus NS2 protein generated by NS2-3 autocleavage is required for NS5A phosphorylation.  Biochem Biophys Res Commun . 1999;  254 572-577
    CrossrefPubMedGoogle Scholar
  • 79 Koch J O, Bartenschlager R. Modulation of hepatitis C virus NS5A hyperphosphorylation by nonstructural proteins NS3, NS4A, and NS4B.  J Virol . 1999;  73 7138-7146
    PubMedGoogle Scholar
  • 80 Neddermann P, Clementi A, De Francesco R. Hyperphosphorylation of the hepatitis C virus NS5A protein requires an active NS3 protease, NS4A/B and NS5A encoded on the same polyprotein.  J Virol . 1999;  73 9984-9991
    PubMedGoogle Scholar
  • 81 Ide Y, Tanimoto A, Sasaguri Y. Hapatitis C virus NS5A protein is phosphorylated in vitro by a stably bound protein kinase from HeLa cells and by cAMP-dependent protein kinase A-αcatalytic subunit.  Gene . 1997;  201 151-158
    CrossrefPubMedGoogle Scholar
  • 82 Reed K E, Xu J, Rice C M. Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: Properties of the NS5A-associated kinase.  J Virol . 1997;  71 7181-7197
    PubMedGoogle Scholar
  • 83 Kim J, Lee D, Choe J. Hepatitis C virus NS5A protein is phorphorylated by casein kinase II.  Biochem Biophys Res Commun . 1999;  257 777-781
    CrossrefPubMedGoogle Scholar
  • 84 Kapoor M, Zhang L, Ramachandra M. Association between NS3 and NS5 proteins of Dengue virus type 2 in the putative RNA replicase is linked to differential phosphorylation of NS5.  J Biol Chem . 1995;  270 19100-19106
    CrossrefPubMedGoogle Scholar
  • 85 Ide Y, Zhang L, Chen M. Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A.  Gene . 1996;  182 203-211
    CrossrefPubMedGoogle Scholar
  • 86 Kato N, Lan K H, Ono-Nita S K. Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator.  J Virol . 1997;  71 8856-8859
    PubMedGoogle Scholar
  • 87 Tanimoto A, Ide Y, Arima N. The amino terminal deletion mutants of hepatitis C virus nonstructural protein NS5A function as transcriptional activators in yeast.  Biochem Biophys Res Commun . 1997;  236 360-364
    CrossrefPubMedGoogle Scholar
  • 88 Chung K M, Song O K, Jang S K. Hepatitis C virus nonstructural protein 5A contains potential transcriptional activator domains.  Mol Cells . 1997;  7 661-667
    PubMedGoogle Scholar
  • 89 Fukuma T, Enomoto N, Marumo F. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region of 5A protein.  Hepatology . 1998;  28 1147-1153
    CrossrefPubMedGoogle Scholar
  • 90 Herion D, Hoofnagle J H. The interferon sensitivity determining region all hepatitis C virus isolates are not the same.  Hepatology . 1997;  25 769-771
    CrossrefPubMedGoogle Scholar
  • 91 Enomoto N I, Sakuma Y, Asahina M. Comparison of full-length sequences of interferon-sensitive and restistant hepatitis C virus 1b.  J Clin Invest . 1995;  96 224-230
    CrossrefPubMedGoogle Scholar
  • 92 Enomoto N I, Sakuma Y, Asahina M. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.  N Engl J Med . 1996;  334 77-81
    CrossrefPubMedGoogle Scholar
  • 93 Chayama K, Tsubota A, Kobayashi M. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection.  Hepatology . 1997;  25 745-749
    CrossrefPubMedGoogle Scholar
  • 94 Komatsu H, Fujisawa T, Inui A. Mutations in the nonstructural protein 5A gene and response to interferon therapy in young patients with chronic hepatitis C virus 1b infection.  J Med Virol . 1997;  3 361-365
    PubMedGoogle Scholar
  • 95 Murakami T, Enomoto N, Kurosaki M. Mutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infection.  Hepatology . 1999;  30 1045-1053
    CrossrefPubMedGoogle Scholar
  • 96 Murashima S, Ide T, Miyajima I. Mutations in the NS5A gene predict response to interferon therapy in japanese peatients with chronic hepatitis C and cirrhosis.  Scand J Infect Dis . 1999;  31 27-32
    PubMedGoogle Scholar
  • 97 Sáiz J C, López-Labrador F X, Ampurdanés S. The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus.  J Infect Dis . 1998;  177 839-847
    PubMedGoogle Scholar
  • 98 Magrin S, Gainguzza F, Alaimo G. HCV NS5A mutations in europeans infected by genotype 1b.  Gastroenterology . 1998;  115 244-245
    PubMedGoogle Scholar
  • 99 Sarrazin C, Berg T, See J H. Improved correlation between multiple mutations within the NS5A region and virological response in European patients chronically infected with hepatitis C virus type 1b undergoing combination therapy.  J Hepatol . 1999;  30 1004-1013
    CrossrefPubMedGoogle Scholar
  • 100 Squadrito G, Leone F, Sartori M. Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alpha.  Gastroenterology . 1997;  113 567-572
    CrossrefPubMedGoogle Scholar
  • 101 Chung R T, Monto A, Dienstag J L. Mutations in the NS5A region do not predict interferon-responsiveness in american patients infected with genotype 1b hepatitis C virus.  J Med Virol . 1999;  58 353-358
    CrossrefPubMedGoogle Scholar
  • 102 Ibarrola N, Moreno-Monteagudo J A, Saiz M. Response to retreatment with interferon-alpha plus ribavirin in chronic hepatitis C patients is independent of the NS5A gene nucleotide sequence.  Am J Gastroenterol . 1999;  94 2487-2495
    PubMedGoogle Scholar
  • 103 Khorsi H, Castelain S, Wyseur A. Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in french patients.  J Hepatol . 1997;  27 72-77
    CrossrefPubMedGoogle Scholar
  • 104 Squadrito G, Orlando M E, Cacciola I. Long-term response to interferon alpha is unrelated to ``interferon sensitivity determining region'' variability in patients with chronic hepatitis C virus-1b infection.  J Hepatol . 1999;  30 1023-1027
    CrossrefPubMedGoogle Scholar
  • 105 Zeuzem S, Lee J H, Roth W K. Mutations in the nonstructural 5A gene of european hepatitis C virus isolates and response to interferon alfa.  Hepatology . 1997;  25 740-744
    CrossrefPubMedGoogle Scholar
  • 106 Gale Jr M, Korth M J, Tang N M. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein.  Virology . 1997;  230 217-227
    CrossrefPubMedGoogle Scholar
  • 107 Gale Jr M, Blakely C N, Kwieciszewski B. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: Molecular mechanisms of kinase regulation.  Mol Cell Biol . 1998;  18 5208-5218
    PubMedGoogle Scholar
  • 108 Gale Jr M, Kwieciszewski B, Dossett M. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase.  J Virol . 1999;  73 6506-6516
    PubMedGoogle Scholar
  • 109 Polyak S J, Paschal D M, McArdle S. Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication.  Hepatology . 1999;  29 1262-1271
    CrossrefPubMedGoogle Scholar
  • 110 Song J, Fujii M, Wang F. The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon.  J Gen Virol . 1999;  80 879-886
    PubMedGoogle Scholar
  • 111 Tan S L, Nakao H, He Y. NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in an Src homogy 3 domain/ligand-dependent manner and perturbs mitogenic signaling.  Proc Natl Acad Sci USA . 1999;  96 5533-5538
    CrossrefPubMedGoogle Scholar
  • 112 Behrens S E, Tomei L, De Francesco R. Identification and properties of the RNA-dependent RNA polymerase of the hepatitis C virus.  EMBO J . 1996;  15 12-22
    PubMedGoogle Scholar
  • 113 De Francesco R, Behrens S E, Tomei L. RNA-dependent RNA polymerase of hepatitis C virus.  Methods Enzymol . 1996;  275 58-67
    PubMedGoogle Scholar
  • 114 Lohman V, Korner F, Herian U. Biochemical properties of the hepatitis C virus RNA-dependent RNA polymerase and identification of the amino acid sequence motifs essential for enzymatic acivity.  J Virol . 1997;  71 8416-8428
    PubMedGoogle Scholar
  • 115 Yuan Z-H, Kumar U, Thomas H C. Expression, purification, and partial characterization of HCV polymerase.  Biochem Biophys Res Commun . 1997;  232 231-235
    CrossrefPubMedGoogle Scholar
  • 116 Al R H, Xie Y, Wang Y, Hagedo C H. Expression of recombinant hepatitis C virus non-structural protein 5B in Escherichia coli Virus Res .  1998;  53 141-149
    PubMedGoogle Scholar
  • 117 Oh J W, Ito T, Lai M C. A recombinant hepatits C virus RNA-dependent RNA-polymerase capable of copying the full-length viral RNA.  J Virol . 1999;  73 7694-7702
    PubMedGoogle Scholar
  • 118 Cheng J C, M-F, Chang S C. Specific interaction between the hepatitis C virus NS5B RNA polymerase and the 3′end of the viral RNA.  J Virol . 1999;  73 7044-7049
    PubMedGoogle Scholar
  • 119 Ishido S, Fujita T, Hotta H. Complex formation of NS5B with NS3 and NS4A proteins of hepatits C virus.  Biochem Biophys Res Commun . 1998;  244 35-40
    CrossrefPubMedGoogle Scholar
  • 120 Poch O, Sauvaget I, Delarue M. Identification of four conserved motifs among the RNA dependent polymerase encoding elements.  EMBO J . 1989;  8 3867-3874
    PubMedGoogle Scholar
  • 121 Yamashita T, Kaneko S, Shirota Y. RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region.  J Biol Chem . 1998;  73 15479-15486
    PubMedGoogle Scholar
  • 122 Ishii K, Tanaka Y, Yap C C. Expression of hepatits C virus NS5B protein: Characterization of its RNA polymerase activity and RNA binding.  Hepatology . 1999;  29 1227:1235
    PubMedGoogle Scholar
  • 123 Lesburg C A, Cable M C, Ferrari E. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus reveals a fully encircled active site.  Nature Struct Biol . 1999;  6 937-943
    CrossrefPubMedGoogle Scholar
  • 124 Bressanelli S, Tomei L, Roussel A. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus.  Proc Natl Acad Sci USA . 1999;  96 13034-13039
    CrossrefPubMedGoogle Scholar
  • 125 Ago H, Adachi T, Yoshida A. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus.  Structure . 1999;  7 1417-1426
    CrossrefPubMedGoogle Scholar
  • 126 Conti E, Uy M, Leighton L. Crystallographic analysis of the recognition of a nuclear localization signal by the nuclear import factor karyopherin alpha.  Cell . 1999;  94 193-204
    PubMedGoogle Scholar
  • 127 Ferrari E, Wright-Minogue J, Fang J WS. Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in E coli .  J Virol. 1999;  73 1649-1654
    PubMedGoogle Scholar
  • 128 Di Bisceglie M A. Hepatitis C.  Lancet . 1998;  351 3511-355
    PubMedGoogle Scholar
  • 129 Alberti A. Therapy of hepatitis C: Re-treatment with alpha interferon.  Hepathology . 1997;  26(Suppl 1) 137-142
    PubMedGoogle Scholar
  • 130 Bancherau J, Rousset F. Human B lymphocytes: Phenotype, proliferation and differentiation.  Adv Immunol . 1992;  52 125-262
    PubMedGoogle Scholar
  • 131 Berke G. The binding and lysis of target cells by cytotoxic lymphocytes: Molecular and cellular aspects.  Annu Rev Immunol . 1994;  12 735-773
    CrossrefPubMedGoogle Scholar
  • 132 Berke G. The CTL's kiss of death.  Cell . 1995;  81 9-12
    CrossrefPubMedGoogle Scholar
  • 133 Guidotti L G, Guilhot S, Chisari F V. Interleukin 2 and interferon alpha/beta downregulate hepatitis B virus gene expression in vivo by tumor necrosis factor dependent and independent pathways.  J Virol . 1994;  68 1265-1270
    PubMedGoogle Scholar
  • 134 Hoffmann R M, Diepolder H M, Zachoval R. Mapping of immunodominant CD4 T lymphocytes epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection.  Hepatology . 1995;  21 632-638
    CrossrefPubMedGoogle Scholar
  • 135 Missale G, Bertoni R, Lamonaca V. different clinical behaviours of acute hepatitis C virus infection are associated with different vigour of the anti-viral cell-mediated immune response.  J Clin Invest . 1996;  98 706-714
    PubMedGoogle Scholar
  • 136 Diepolder H M, Gerlach J T, Zachoval R. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatits C virus infection.  J Virol . 1997;  71 6011-6019
    PubMedGoogle Scholar
  • 137 Diepolder H M, Zachoval R, Hoffmann R M. The role of hepatitis C virus specific CD4+ T-lymphocytes in acute and chronic hepatitis C.  J Mol Med . 1996;  74 583-588
    CrossrefPubMedGoogle Scholar
  • 138 Diepolder H M, Zachoval R, Hoffmann R M. Possible mechanism involving T lymphocyte response to nonstructural protein 3 in viral clearance in acute hepatits C virus infection.  Lancet . 1995;  346 1006-1007
    CrossrefPubMedGoogle Scholar
  • 139 Romagnani S. Lymphokine production by human T cells in disease states.  Annu Rev Immunol . 1994;  12 227-257
    CrossrefPubMedGoogle Scholar
  • 140 Tsai S-L, Liaw Y-F, Chen M-H. Detection of type 2-like T-helper cells in hepatitis C virus infection: Implications for hepatitis C chronicity.  Hepatology . 1997;  25 449-458
    PubMedGoogle Scholar
  • 141 Koziel M J, Wong D KH, Dudley D. Hepatitis C virus-specific cytolitic T lymphocytes and T helper cell responses in seronegative persons.  J Infect Dis . 1997;  176 859-866
    PubMedGoogle Scholar
  • 142 Scognamiglio P, Accapezzato D, Casciaro M A. Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors.  J Immunol . 1999;  162 6681-6689
    PubMedGoogle Scholar
  • 143 Rehermann B. Cellular immune response to the hepatitis C virus.  J Viral Hepat . 1999;  6(Suppl 1) 31-35
    CrossrefPubMedGoogle Scholar
  • 144 Rehermann B, Chang K M, McHutchinson J. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients.  J Virol . 1996;  70 7092-7102
    PubMedGoogle Scholar
  • 145 Hiroishi K, Kita H, Kojima M. Cytotoxic T lymphocytes response and viral load in hepatitis C virus infection.  Hepatology . 1997;  25 705-712
    CrossrefPubMedGoogle Scholar
  • 146 Nelson D R, Marousis C G, Davis G L. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C.  J Immunol . 1997;  158 1473-1481
    PubMedGoogle Scholar
  • 147 Weiner A J, Erickson A L, Kansopon J. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant.  Proc Natl Acad Sci USA . 1995;  92 2755-2759
    PubMedGoogle Scholar
  • 148 Cooper S, Erickson A L, Adams E J. Analysis of a successful immune response against hepatitis C virus.  Immunity . 1999;  10 439-449
    CrossrefPubMedGoogle Scholar
  • 149 Zibert A, Meisel H, Kraas W. Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus.  Hepatology . 1997;  25 1245-1249
    CrossrefPubMedGoogle Scholar
  • 150 Ishii K, Rosa D, Watanabe Y. High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C.  Hepatology . 1998;  28 1117-1120
    CrossrefPubMedGoogle Scholar
      >